tga

A patient who used an unapproved peptide labelled as the weight-loss drug retatrutide suffered a potentially fatal torn oesophagus after experiencing uncontrollable vomiting, according to a warning issued by the Therapeutic Goods Administration (TGA). Laboratory testing revealed the product contained no retatrutide, but instead held an exceptionally high dose of undeclared semaglutide. TGA Warning Over … Read more